Literature DB >> 8383131

Neutrophils stimulated with a chemotactic peptide or a phorbol ester exhibit different alterations in the activities of a battery of protein kinases.

J Ding1, J A Badwey.   

Abstract

Protein kinases in neutrophils that undergo changes in activity during cell stimulation have been investigated by two recently described procedures. These methods are based on the ability of renatured kinases to undergo autophosphorylation or to phosphorylate protein substrates fixed in gels. Using these techniques, we report that neutrophils contain a battery of protein kinases with molecular masses of 65-61 kDa (termed "group A kinases") that are rapidly activated upon stimulation of the cells with the chemotactic peptide N-fMet-Leu-Phe (fMLP). Activity was maximal within 30 s with this stimulus and returned to the basal level seen in unstimulated cells within 3 min. In contrast, stimulation of neutrophils with 4 beta-phorbol 12-myristate 13-acetate resulted in a diminution of these kinase activities. Treatment of neutrophils with antagonists of type 1 and 2A protein phosphatases (calyculin A, okadaic acid) inhibited the activation of the group A kinases by fMLP, whereas norokadanone, an analog of okadaic acid that is a poor inhibitor of protein phosphatases, had no effect. Exposure of neutrophils to calyculin A alone resulted in the activation of several additional protein kinases with molecular masses different from the group A kinases. These data indicate that the signal transduction pathways of neutrophils are likely to be far more complicated than previously appreciated and involve a number of uncharacterized protein kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Characterization and partial purification of a novel neutrophil membrane-associated kinase capable of phosphorylating the respiratory burst component p47phox.

Authors:  A S Lal; P J Parker; A W Segal
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  An apparently novel protein of human leukocytes, reactive with an antibody to protein kinase C-gamma, is rapidly modified upon cell activation: initial characterization in neutrophils and their cytoplasts.

Authors:  J I Smallwood; S E Malawista
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

3.  Characterization of membrane-localized and cytosolic Rac-GTPase-activating proteins in human neutrophil granulocytes: contribution to the regulation of NADPH oxidase.

Authors:  M Geiszt; M C Dagher; G Molnár; A Havasi; J Faure; M H Paclet; F Morel; E Ligeti
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  Electrogenic H+ pathway contributes to stimulus-induced changes of internal pH and membrane potential in intact neutrophils: role of cytoplasmic phospholipase A2.

Authors:  K Suszták; A Mócsai; E Ligeti; A Kapus
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Phosphorylation of the leucocyte NADPH oxidase subunit p47(phox) by casein kinase 2: conformation-dependent phosphorylation and modulation of oxidase activity.

Authors:  H S Park; S M Lee; J H Lee; Y S Kim; Y S Bae; J W Park
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

Review 6.  The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view.

Authors:  J M Robinson; J A Badwey
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

7.  Neutrophils stimulated with a variety of chemoattractants exhibit rapid activation of p21-activated kinases (Paks): separate signals are required for activation and inactivation of paks.

Authors:  R Huang; J P Lian; D Robinson; J A Badwey
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  Modulation of the alveolar macrophage superoxide production by protein phosphorylation.

Authors:  H J Forman; H Zhou; E Gozal; M Torres
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.